Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells
2018 · Frontiers in Oncology · 207 citations
https://doi.org/10.3389/fonc.2018.00347
F
Farah Ballout
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
729
Citations
13
h-index
16
i10-index
Farah Ballout is an academic researcher from University of Miami. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Gastrointestinal Tumor Research and Treatment & Pancreatic and Hepatic Oncology Research. The author has an h-index of 13, co-authored 71 publications.
ORCID: 0000-0002-6399-9179Papers by this author
worksAPE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas
2022 · Journal of Experimental & Clinical Cancer Research · 25 citations
https://doi.org/10.1186/s13046-022-02472-5
Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
2024 · Clinical Cancer Research · 8 citations
https://doi.org/10.1158/1078-0432.ccr-24-0027
ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoids
2024 · Pharmacological Reports · 5 citations
https://doi.org/10.1007/s43440-024-00676-4
Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors
2025 · International Journal of Molecular Sciences · 5 citations
https://doi.org/10.3390/ijms26051992
Enhancing the antitumor efficacy using a combination of FGFR4 Inhibitor (H3B-6527) and oxaliplatin in gastric cancer
2025 · Neoplasia · 1 citations
https://doi.org/10.1016/j.neo.2025.101257
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat